As of Mar 28
| +6.80 / +0.83%|
The 22 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals Inc have a median target of 891.50, with a high estimate of 1,040.00 and a low estimate of 605.00. The median estimate represents a +7.77% increase from the last price of 827.21.
The current consensus among 27 polled investment analysts is to Buy stock in Regeneron Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.